Patents Assigned to Trin Therapeutics GmbH
  • Patent number: 8426390
    Abstract: The present invention relates to novel triazene compounds, to a process for their preparation, to pharmaceutical compositions comprising them, and to the use thereof in the treatment of cancer diseases in humans. The novel triazene compounds are distinguished, as compared with the known triazene compounds, by improved activity while at the same time having reduced toxicity, that is to say by fewer side-effects.
    Type: Grant
    Filed: August 9, 2011
    Date of Patent: April 23, 2013
    Assignee: Trin Therapeutics GmbH
    Inventors: Rudolf Reiter, Jochen Kalbe, Heinz Forster
  • Publication number: 20120028927
    Abstract: The present invention relates to novel triazene compounds, to a process for their preparation, to pharmaceutical compositions comprising them, and to the use thereof in the treatment of cancer diseases in humans. The novel triazene compounds are distinguished, as compared with the known triazene compounds, by improved activity while at the same time having reduced toxicity, that is to say by fewer side-effects.
    Type: Application
    Filed: August 9, 2011
    Publication date: February 2, 2012
    Applicant: TRIN THERAPEUTICS GMBH
    Inventors: Rudolf Reiter, Jochen Kalbe, Heinz Forster
  • Patent number: 8034797
    Abstract: The present invention relates to novel triazene compounds, to a process for their preparation, to pharmaceutical compositions comprising them, and to the use thereof in the treatment of cancer diseases in humans. The novel triazene compounds are distinguished, as compared with the known triazene compounds, by improved activity while at the same time having reduced toxicity, that is to say by fewer side-effects.
    Type: Grant
    Filed: July 3, 2008
    Date of Patent: October 11, 2011
    Assignee: Trin Therapeutics GmbH
    Inventors: Rudolf Reiter, Jochen Kalbe, Heinz Forster